BLOG / 🇺🇸 United States / earnings results · · daily

US Earnings Financial Results SEC Filings — August 10, 2026

Financial Results & Earnings

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The 50 filings for the period ending August 10, 2026, reveal a market characterized by stark divergence: established companies like Yum China, Brookfield Asset Management, and Berkshire Hathaway are posting strong operational results and returning significant capital to shareholders, while a cluster of pre-revenue and early-stage firms (Blue Biofuels, BTC Development, Invest Green Acquisition) continue to burn cash with no clear path to profitability.

A notable theme is the prevalence of 'mixed' sentiment, with many companies showing top-line growth but facing margin compression or one-time charges that obscure underlying performance. Key period-over-period trends include a surge in M&A and divestiture activity (Plains All American, Berkshire Hathaway, Lincoln International), aggressive share repurchases (Corpay, Yum China, Berkshire Hathaway), and a sharp increase in operating expenses outpacing revenue growth at several firms (Axsome Therapeutics, Lincoln International, IonQ). The most critical development is the massive, non-cash-driven net income swings at companies like IonQ and Lincoln International, which require careful analysis to separate operational reality from accounting noise. Portfolio-level patterns point to a 'barbell' market where capital is flowing to either proven cash generators or high-risk, high-reward speculative plays, with the middle ground under significant pressure.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-Q

Tracking the trend? Catch up on the prior US Earnings Financial Results SEC Filings digest from August 07, 2026.

Investment Signals (12)

  • Yum China Holdings ↓ (BULLISH)
    ▲

    Revenue grew 12.6% YoY in Q2, net income up 13.5%, and the company aggressively repurchased 6M shares (vs 4M in Q2 2025), signaling strong operational momentum and management confidence in intrinsic value.

  • Brookfield Asset Management ↓ (BULLISH)
    ▲

    Net income surged 45.8% YoY to $904M, driven by a $616M swing in unrealized carried interest, while total revenues grew 60.8%, indicating strong fee-related earnings power and a robust investment pipeline.

  • Corpay ↓ (BULLISH)
    ▲

    Revenue grew 21.5% YoY, but net income declined 12.6% due to a $100M legal provision. The company aggressively deployed $1.11B in buybacks in H1 2026, signaling management's view that the stock is undervalued despite the legal overhang.

  • IonQ ↓ (MIXED)
    ▲

    Revenue surged 287% YoY to $80M, demonstrating explosive customer adoption. However, the net loss ballooned to $1.87B from $177.5M due to a $1.65B non-cash warrant liability charge, making the underlying operational trend difficult to assess.

  • Berkshire Hathaway ↓ (BULLISH)
    ▲

    Net earnings doubled to $25.7B, operating revenues grew 10%, and the company spent $4.5B on buybacks in Q2 alone. However, cash and equivalents fell sharply to $35.1B from $47.7B, signaling a more aggressive deployment of capital into equities and acquisitions.

  • Plains All American Pipeline ↓ (BULLISH)
    ▲

    Net income surged to $1.83B from $210M, driven by a $1.65B gain from the Canadian NGL divestiture. The company used proceeds to reduce long-term debt by $2.26B, strengthening the balance sheet significantly.

  • Goldman Sachs Private Credit ↓ (BEARISH)
    ▲

    Net investment income grew 45.7% YoY to $218.9M, but NAV per share declined to $24.57 from $24.99, and distributable earnings turned deeply negative (-$226.2M), signaling potential credit quality stress.

  • Silence Therapeutics ↓ (MIXED)
    ▲

    Net loss improved to $12.3M from $27.4M, with operating cash burn reduced by 58.7%. However, revenue fell to zero as the AstraZeneca collaboration paused, and short-term investments were liquidated, raising questions about the sustainability of the cash runway.

  • Lincoln International ↓ (MIXED)
    ▲

    Revenue grew 50.8% YoY to $225.7M, but the company swung to a $22.95M net loss from a $33.54M profit due to a 105.6% surge in expenses, including a $28.68M non-cash charge for IPO-related share awards. The IPO raised $451.5M, providing a new capital base.

  • Vistra Corp ↓ (BULLISH)
    ▲

    H1 2026 net income surged to $1.24B from a $37M loss in H1 2025, driven by improved margins and lower impairments. Operating cash flow nearly doubled to $2.22B, providing ample coverage for increased capex of $1.57B.

  • Galaxy Gaming ↓ (BULLISH)
    ▲

    Net income for H1 2026 was $2.36M versus a $1.07M loss in H1 2025, driven by strong EMEA growth (+15.1% in Q2). Total liabilities decreased, and the stockholders' deficit narrowed, indicating a balance sheet improvement.

  • Hims & Hers Health ↓ (NEUTRAL)
    ▲

    (No detailed enriched data provided, but included in filings) The company is a high-growth telehealth player; its filing should be monitored for revenue growth trends and regulatory updates on compounded GLP-1s.

Risk Flags (10)

  • Blue Biofuels / Cash Runway↓ [HIGH RISK]
    ▼

    Cash and equivalents fell 66% to just $22,040, with a working capital deficit of $3.34M. Operating cash burn more than doubled to $687K in H1 2026, and the company has no revenue. This is a going-concern risk.

  • American Rebel Holdings / Revenue Decline↓ [HIGH RISK]
    ▼

    Revenue declined 30% YoY to $1.99M, and the company posted a negative gross margin of $156K. Cash fell to just $96K, and interest expense rose 71.6% YoY, indicating severe financial distress.

  • General Enterprise Ventures / Cash Burn↓ [HIGH RISK]
    ▼

    Cash reserves fell 60% to $2.52M, while operating cash burn doubled to $3.84M in H1 2026. Revenue declined 59% YoY, and operating losses widened, suggesting the company is rapidly consuming capital with no top-line growth.

  • Expion360 / Sales Decline & Cash Burn↓ [HIGH RISK]
    ▼

    Net sales declined 32% YoY in Q2, and the H1 net loss widened to $3.04M. Cash dropped to $1.54M from $2.97M, and operating cash burn increased to $2.61M, signaling a deteriorating liquidity position.

  • Goldman Sachs Private Credit / NAV & Credit Stress↓ [HIGH RISK]
    ▼

    NAV per share declined to $24.57 from $24.99, and distributable earnings worsened to -$226.2M. Interest expenses surged 165% YoY, and net realized/unrealized losses expanded to $179.4M in H1, indicating potential credit quality deterioration in the portfolio.

  • Axsome Therapeutics / Widening Losses↓ [MEDIUM RISK]
    ▼

    Despite 45.6% revenue growth, net loss widened to $51.3M from $48.0M due to a 59.8% surge in SG&A expenses. Accounts receivable and inventories are growing faster than revenue, potentially signaling collection or demand issues.

  • BTC Development Corp / No Revenue & Rising Costs↓ [MEDIUM RISK]
    ▼

    The SPAC has no operating revenue, and operating losses surged 110x to $408K in Q2. Cash declined 43% to $1.12M, and the company is burning cash with no identified acquisition target, facing a ticking clock on its business combination deadline.

  • Outdoor Holding Co / Equity Decline↓ [MEDIUM RISK]
    ▼

    Despite a swing to profitability, equity declined sequentially due to share repurchases and preferred dividends. The company's capital allocation strategy may be prioritizing buybacks over balance sheet strength.

  • iHeartMedia / Debt Load↓ [MEDIUM RISK]
    ▼

    (No detailed enriched data provided, but included in filings) The company carries a significant debt load from its 2019 emergence from bankruptcy. Its filing should be monitored for debt reduction progress and advertising revenue trends.

  • Douglas Elliman / Real Estate Slowdown↓ [MEDIUM RISK]
    ▼

    (No detailed enriched data provided, but included in filings) As a residential real estate brokerage, the company is highly sensitive to interest rates and housing market activity. Its filing should be watched for transaction volume declines.

Opportunities (10)

  • Yum China / Aggressive Buyback & Growth↓ (OPPORTUNITY)
    ◆

    The company is growing revenue (12.6% YoY) and earnings (13.5% YoY) while aggressively reducing share count (6M shares bought in Q2). This combination of operational growth and capital return creates a powerful EPS compounding story.

  • Berkshire Hathaway / Capital Deployment Shift↓ (OPPORTUNITY)
    ◆

    With cash declining from $47.7B to $35.1B and $9.7B spent on acquisitions in H1 2026, Berkshire is signaling a more aggressive deployment of its 'dry powder'. This could lead to accretive deals and higher intrinsic value growth.

  • Plains All American / Post-Divestiture Strength↓ (OPPORTUNITY)
    ◆

    The Canadian NGL divestiture has significantly delevered the balance sheet (debt down $2.26B). The company's continuing operations are generating strong cash flow ($1.21B in H1), which could support increased distributions or further debt reduction.

  • IonQ / Quantum Computing Growth↓ (OPPORTUNITY)
    ◆

    Revenue grew 287% YoY, demonstrating that quantum computing is transitioning from theory to commercial reality. While the net loss is distorted by non-cash charges, the underlying business is scaling rapidly, making it a high-risk, high-reward play on a transformative technology.

  • Brookfield Asset Management / Fee Income Growth↓ (OPPORTUNITY)
    ◆

    With total revenues up 60.8% and a massive swing in carried interest, Brookfield is benefiting from a strong fundraising and investment environment. The company's asset-light fee model provides operating leverage as AUM grows.

  • Vistra Corp / Earnings Turnaround & Cash Flow↓ (OPPORTUNITY)
    ◆

    The swing from a $37M loss to a $1.24B profit in H1 is dramatic. Operating cash flow of $2.22B provides strong coverage for capex and debt service, and the company's nuclear and renewable assets are well-positioned for the AI-driven power demand surge.

  • Galaxy Gaming / International Growth & Deleveraging↓ (OPPORTUNITY)
    ◆

    EMEA revenue grew 15.1% in Q2, and the company is reducing total liabilities and narrowing its stockholders' deficit. If the Americas segment stabilizes, the company could see significant earnings leverage.

  • Corpay / Buyback Opportunity↓ (OPPORTUNITY)
    ◆

    The $1.11B in buybacks in H1 2026 represents a significant capital return. If the $100M legal provision is a one-time event, the underlying earnings power is strong, and the reduced share count will boost future EPS.

  • Silence Therapeutics / Reduced Cash Burn↓ (OPPORTUNITY)
    ◆

    Operating cash burn improved by 58.7% to $14.1M in H1 2026. If the company can secure a new partnership or advance its pipeline, the extended runway provides a cushion for value creation.

  • Eastern Gas Transmission & Storage / Asset Sale Catalyst↓ (OPPORTUNITY)
    ◆

    The company has $2.01B in assets held for sale. A successful disposition could unlock significant value and be used for debt reduction or special dividends.

Sector Themes (6)

  • Divestiture-Driven Balance Sheet Repair
    ◆

    Multiple companies (Plains All American, Plains GP Holdings, Eastern Gas) are using asset sales to delever. Plains All American reduced debt by $2.26B post-divestiture, while Eastern Gas has $2B in assets for sale. This trend suggests a focus on simplifying portfolios and strengthening balance sheets in capital-intensive industries.

  • Aggressive Buybacks vs. Organic Investment
    ◆

    A clear bifurcation is emerging. Cash-rich companies like Berkshire Hathaway ($4.5B in Q2), Yum China (6M shares), and Corpay ($1.11B in H1) are aggressively buying back stock. In contrast, growth-stage companies like IonQ and Axsome are pouring cash into R&D and SG&A, with no buybacks. This suggests a market where mature companies see their own stock as the best investment, while growth companies are still in investment mode.

  • Revenue Growth Outpacing Profitability
    ◆

    A common theme across Axsome Therapeutics, Lincoln International, and IonQ is that revenue is growing rapidly (45-287% YoY), but expenses are growing even faster, leading to wider net losses or margin compression. This points to a 'growth at all costs' mentality that may be tested if capital markets tighten.

  • Non-Cash Charges Distorting Earnings
    ◆

    Several companies reported massive swings in net income due to non-cash items: IonQ ($1.65B warrant liability), Lincoln International ($28.7M IPO share awards), and Plains All American ($1.65B divestiture gain). Investors must look at operating cash flow and adjusted earnings to get a true picture of underlying performance.

  • Private Credit Under Pressure
    ◆

    Goldman Sachs Private Credit Corp showed strong NII growth (+45.7% YoY) but declining NAV and worsening distributable earnings. This suggests that while interest income is high, credit quality is deteriorating, a potential leading indicator for the broader private credit market.

  • Energy Sector Cash Flow Strength
    ◆

    Vistra Corp, Plains All American, and Eastern Gas all reported strong operating cash flows. Vistra's H1 cash flow doubled to $2.22B, and Plains' continuing ops generated $1.21B. This cash generation is supporting debt reduction, buybacks, and capex, making the sector a source of reliable cash returns.

Watch List (8)

  • Blue Biofuels / Going Concern Risk↓
    👁

    With only $22K in cash and a $3.34M working capital deficit, the company is likely to require a dilutive financing or face bankruptcy. Watch for a reverse stock split or emergency funding announcement.

  • Goldman Sachs Private Credit / Credit Quality↓
    👁

    The decline in NAV and worsening distributable earnings warrant close monitoring. The next quarterly filing will be critical to see if credit losses are accelerating. Watch for an increase in non-accruals.

  • IonQ / Q3 2026 Earnings↓
    👁

    After a 287% revenue surge, the market will be watching for sustained growth and a path to operational profitability. The next earnings call will be key for forward guidance on customer contracts and cash burn.

  • Corpay / Legal Resolution↓
    👁

    The $100M legal provision is a significant overhang. Watch for updates on the settlement or litigation outcome, which could remove a key uncertainty and allow the market to focus on the strong underlying business.

  • Eastern Gas Transmission & Storage / Asset Sale↓
    👁

    The $2B in assets held for sale is a major catalyst. Watch for an announcement of a buyer and terms, which could unlock significant shareholder value.

  • American Rebel Holdings / Liquidity Crisis↓
    👁

    With cash at $96K and negative gross margins, the company is in a precarious position. Watch for a going concern qualification in the next filing or a distressed financing.

  • Lincoln International / Post-IPO Performance↓
    👁

    The company's first quarter as a public entity was messy due to IPO-related charges. Watch for Q3 results to see if the underlying business can generate a profit on the much larger revenue base.

  • Hims & Hers Health / Regulatory Update↓
    👁

    The company's growth is tied to the regulatory status of compounded GLP-1 drugs. Watch for FDA announcements or legal rulings that could impact its core product offering.

Filing Analyses (50)
James River Group Holdings, Inc. 10-Q materiality 6/10

10-08-2026

Silence Therapeutics plc 10-Q mixed materiality 8/10

10-08-2026

Silence Therapeutics plc reported a net loss of $12.3 million for Q2 2026, a significant improvement from the $27.4 million net loss in Q2 2025, driven by reduced R&D costs and foreign currency gains. Revenue fell to zero in Q2 2026 from $0.2 million in the prior year, as the AstraZeneca collaboration had no revenue in the quarter, while total six-month revenue increased to $0.4 million from $0.4 million (flat). Operating loss narrowed to $13.9 million from $24.0 million, but the company still has an accumulated deficit of $589.6 million.

  • · Non-current assets decreased from $12.8M at Dec 2025 to $12.1M at June 2026, mainly due to reductions in UK and Germany segments.
  • · Net cash used in operations improved to $14.1M in H1 2026 from $34.1M in H1 2025, a 58.7% reduction.
  • · The company had no short-term investments as of June 30, 2026, down from $73.8M at Dec 2025, as funds were likely moved to cash equivalents.
  • · R&D benefit receivable decreased by $12.7M in H1 2026, reflecting cash collections.
  • · Total liabilities decreased slightly to $67.9M from $69.1M.
  • · Share-based compensation expense was $3.8M in H1 2026 vs $5.6M in H1 2025, a 33.2% decline.
Greystone Housing Impact Investors LP 10-Q materiality 6/10

10-08-2026

BayCom Corp 10-Q materiality 6/10

10-08-2026

LION COPPER & GOLD CORP. 10-Q materiality 6/10

10-08-2026

CEVA INC 10-Q materiality 6/10

10-08-2026

GAIA, INC 10-Q materiality 6/10

10-08-2026

PROKIDNEY CORP. 10-Q materiality 6/10

10-08-2026

Bowman Consulting Group Ltd. 10-Q materiality 6/10

10-08-2026

AST SpaceMobile, Inc. 10-Q materiality 6/10

10-08-2026

Douglas Elliman Inc. 10-Q materiality 6/10

10-08-2026

Keurig Dr Pepper Inc. 10-Q materiality 6/10

10-08-2026

Rumble Inc. 10-Q materiality 6/10

10-08-2026

GoPro, Inc. 10-Q materiality 6/10

10-08-2026

ACV Auctions Inc. 10-Q materiality 6/10

10-08-2026

MOTORCAR PARTS OF AMERICA INC 10-Q materiality 6/10

10-08-2026

iHeartMedia, Inc. 10-Q materiality 6/10

10-08-2026

Rocket Lab Corp 10-Q materiality 6/10

10-08-2026

HighPeak Energy, Inc. 10-Q materiality 6/10

10-08-2026

NATURAL GAS SERVICES GROUP INC 10-Q materiality 6/10

10-08-2026

NEPHROS INC 10-Q materiality 6/10

10-08-2026

GCM Grosvenor Inc. 10-Q materiality 6/10

10-08-2026

Outdoor Holding Co 10-Q mixed materiality 8/10

10-08-2026

Outdoor Holding Co (POWWP) reported a strong turnround in Q1 FY26, swinging to net income from continuing operations of $3.57M from a $5.86M loss in the prior-year quarter. Revenue increased 22.1% YoY to $14.48M, driven by a significant reduction in operating expenses. However, cash flow from operations was positive at $4.43M vs a $6.67M use last year, and the company continued share repurchases, though equity declined sequentially due to buybacks and preferred dividends.

  • · Interest expense fell to $244,363 from $348,330 YoY, a 30% reduction.
  • · Selling and marketing expenses dropped 49.2% YoY to $28,693.
  • · Depreciation and amortization increased marginally to $3,713,954 from $3,510,021.
  • · Common stock outstanding decreased to 116,015,388 from 116,902,624 at March 31, 2026, reflecting share repurchases.
  • · The company spent $2.04M on a common stock repurchase plan during the quarter.
  • · Accounts payable declined to $14.38M from $15.74M, and accrued liabilities dropped to $2.22M from $4.24M.
  • · Goodwill remained flat at $90.87M; other intangible assets net decreased to $83.87M from $86.89M.
  • · No discontinued operations in Q1 FY26 vs a $0.60M loss in Q1 FY25.
  • · Net cash used in financing activities increased to $3.09M from $0.81M YoY, driven by the share repurchase plan.
  • · A $51M note payable was issued in prior year for a DE Litigation settlement (non-cash).
  • · Cash paid for interest increased to $780,000 from $166,107 YoY.
SMARTFINANCIAL INC. 10-Q materiality 6/10

10-08-2026

PennantPark Floating Rate Capital Ltd. 10-Q materiality 6/10

10-08-2026

BRIGHTHOUSE LIFE INSURANCE Co 10-Q materiality 6/10

10-08-2026

BRT Apartments Corp. 10-Q materiality 6/10

10-08-2026

Sable Offshore Corp. 10-Q materiality 6/10

10-08-2026

BTC Development Corp. 10-Q mixed materiality 7/10

10-08-2026

BTC Development Corp. (BDCIU) filed its Form 10-Q for the quarter ended June 30, 2026, reporting net income of $1.87M for Q2 2026 and $3.57M for the first half of 2026, compared to net losses of $3,668 and $39,294 in the same periods of 2025. The improvement was driven by $2.28M (Q2) and $4.52M (H1) in interest earned on marketable securities held in its Trust Account. However, operating losses widened significantly to $408,607 (Q2) and $949,368 (H1) from just $3,668 and $39,294 a year earlier, and cash declined 43% to $1.12M from $1.99M at year-end 2025, reflecting ongoing cash burn with no operating revenue.

  • · The company had no operating revenue in any period presented.
  • · Operating losses (formation, G&A) surged to $408,607 in Q2 2026 from $3,668 in Q2 2025, a 110x increase.
  • · Cash used in operating activities was $861,079 in H1 2026 vs. $0 in H1 2025.
  • · Accrued expenses more than tripled to $80,693 from $21,958 at year-end 2025.
  • · The company's accumulated deficit grew 11% to $9.56M from $8.61M.
  • · Class A shares subject to possible redemption were 25,300,000 shares at a redemption value of $10.26 per share as of June 30, 2026.
  • · The company had $259.5M in a Trust Account, up 1.8% from $255.0M at year-end 2025, entirely from interest income.
  • · Deferred underwriting fee payable remained unchanged at $10.78M.
AMERICAN REBEL HOLDINGS INC 10-Q mixed materiality 8/10

10-08-2026

American Rebel Holdings reported a net loss of $5.98M for Q2 2026, a significant improvement from the $18.14M loss in Q2 2025, driven by lower loss on debt extinguishment and remeasurement of liabilities. However, revenue declined 30% YoY to $1.99M, and the company posted a negative gross margin of $156K. Cash and cash equivalents fell sharply to $96K from $148K at year-end 2025, while total assets decreased to $27.7M from $31.8M.

  • · Revenue mix shifted: safes declined from 95.1% to 88.3% of revenue in Q2, while rental (new segment) contributed 8.0%.
  • · Operating expenses increased 9.8% YoY in Q2 to $4.57M, driven by higher marketing and administrative costs.
  • · Interest expense rose 71.6% YoY in Q2 to $738K, reflecting higher debt levels.
  • · Loss on debt extinguishment improved dramatically from $11.82M in Q2 2025 to $172K in Q2 2026.
  • · Remeasurement and loss on settlement of liabilities improved from $1.69M to $328K in Q2.
  • · Working capital loans decreased from $19.62M at Dec 31, 2025 to $14.61M at June 30, 2026.
  • · Accounts payable increased 37.9% to $4.83M, while accrued expenses more than doubled to $1.85M.
  • · Noncontrolling interest in American Rebel Licensing NIL I, Inc. was $(13,575) at June 30, 2026.
  • · Series E preferred stock dividends of $14K were declared in Q2 2026 (none in Q2 2025).
  • · Basic and diluted loss per share improved from $(213,385.21) in Q2 2025 to $(0.59) in Q2 2026 due to massive share count increase.
NewtekOne, Inc. 10-Q materiality 6/10

10-08-2026

Hims & Hers Health, Inc. 10-Q materiality 6/10

10-08-2026

Crescent Capital BDC, Inc. 10-Q materiality 6/10

10-08-2026

Axsome Therapeutics, Inc. 10-Q mixed materiality 8/10

10-08-2026

Axsome Therapeutics reported strong revenue growth for Q2 and H1 2026, with total revenues up 45.6% YoY in Q2 to $218,375 thousand and up 50.9% YoY in H1 to $409,578 thousand, driven primarily by product sales. However, the company's net loss widened in both periods (Q2 net loss of $51,314 thousand vs. $47,973 thousand; H1 net loss of $115,856 thousand vs. $107,386 thousand) due to a significant increase in SG&A expenses, which rose 59.8% YoY in Q2. Cash and cash equivalents decreased slightly to $319,850 thousand as of June 30, 2026, from $322,933 thousand at year-end 2025, while total assets increased to $761,447 thousand.

  • · Accounts receivable, net increased to $277,459 thousand at June 30, 2026 from $224,464 thousand at December 31, 2025.
  • · Inventories, net increased to $37,883 thousand at June 30, 2026 from $27,938 thousand at December 31, 2025.
  • · Intangible asset, net decreased to $37,358 thousand at June 30, 2026 from $40,519 thousand at December 31, 2025, with remaining weighted-average useful life of 6 years.
  • · Total liabilities increased to $678,143 thousand at June 30, 2026 from $601,510 thousand at December 31, 2025.
  • · Accumulated deficit widened to $1,421,817 thousand at June 30, 2026 from $1,305,961 thousand at December 31, 2025.
  • · Net loss per share (basic and diluted) was $0.99 for Q2 2026 vs $0.97 for Q2 2025, and $2.25 for H1 2026 vs $2.18 for H1 2025.
  • · Stock-based compensation expense was $50,586 thousand for H1 2026 vs $47,919 thousand for H1 2025.
  • · Proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan were $51,949 thousand for H1 2026 vs $28,696 thousand for H1 2025.
  • · Contingent consideration (current and non-current) totaled $80,334 thousand at June 30, 2026 vs $87,552 thousand at December 31, 2025.
  • · Short-term borrowings remained at $70,000 thousand at June 30, 2026 and December 31, 2025.
  • · Loan payable, long-term was $117,958 thousand at June 30, 2026 vs $117,746 thousand at December 31, 2025.
  • · Interest paid was $5,969 thousand for H1 2026 vs $8,359 thousand for H1 2025.
  • · Estimated amortization expense for the finite-lived intangible asset is $3,214 thousand for 2026, $6,375 thousand for 2027, $6,392 thousand for 2028, $6,375 thousand for 2029, $6,375 thousand for 2030, and $8,627 thousand thereafter.
BLUE BIOFUELS, INC. 10-Q negative materiality 8/10

10-08-2026

Blue Biofuels, Inc. reported a net loss of $750,795 for the June quarter of 2026, an improvement from a $920,752 loss a year earlier. However, the six-month net loss widened to $1,414,596 from $1,164,585, as the prior-year period included $444,970 in grant income that was absent in fiscal 2026. The company continues to generate no revenue and ended the quarter with cash and equivalents of only $22,040, a 66% decline from year-end 2025. Total shareholders' deficit deepened to $4,058,672 from $3,706,083.

  • · Cash used in operating activities for the six months ended June 30, 2026 was $687,359, more than double the $298,723 used in the same period of 2025.
  • · Net cash provided by financing activities totaled $702,000 in the first half of 2026, up from $451,250 a year earlier, primarily from issuances of common stock, warrants, and notes.
  • · The company's current liabilities of $3,375,368 exceeded current assets of $34,091 at June 30, 2026, indicating a working capital deficit of approximately $3.34 million.
  • · Deferred wages and directors fees – related parties rose to $2,859,070 from $2,525,135 at year-end 2025, increasing by 13.2%.
  • · No revenue was recorded for any period presented.
Yum China Holdings, Inc. 10-Q positive materiality 8/10

10-08-2026

Yum China Holdings, Inc. reported strong financial results for Q2 and H1 2026, with total revenues increasing 12.6% to $3,138 million in Q2 and 11.1% to $6,409 million year-to-date. Net income attributable to Yum China rose 13.5% to $244 million in Q2 and 9.1% to $553 million year-to-date. However, the company experienced a decline in basic weighted-average shares outstanding (down 6.7% in Q2 and 6.4% year-to-date) due to significant share repurchases ($530 million year-to-date), and interest income decreased sharply by 51.9% in Q2 and 45.1% year-to-date.

  • · Cash and cash equivalents decreased from $506M at Dec 31, 2025 to $485M at June 30, 2026.
  • · Total assets increased by $88M from $10.783B at Dec 31, 2025 to $10.871B at June 30, 2026.
  • · The company repurchased and retired 6 million shares of common stock in Q2 2026, compared to 4 million shares in Q2 2025.
  • · Yum China paid $203 million in cash dividends on common stock in H1 2026, up 12.8% from $180M in H1 2025.
  • · Cash dividends declared per common share increased 20.8% from $0.24 to $0.29.
  • · Capital spending increased 4.6% to $271M in H1 2026 from $259M in H1 2025.
  • · KFC segment company sales were $2,294M in Q2 2026, Pizza Hut $604M, and All Other Segments $12M.
  • · Net cash used in financing activities was $739M in H1 2026 vs $709M in H1 2025.
  • · Equity in net earnings from equity method investments remained unchanged at $2M in Q2 and $4M in H1.
BERKSHIRE HATHAWAY INC 10-Q mixed materiality 9/10

10-08-2026

Berkshire Hathaway reported strong Q2 2026 results with net earnings attributable to shareholders surging to $25.7B from $12.4B in Q2 2025, driven by $16.1B in investment gains versus $6.4B a year ago. Operating revenues grew 10% to $101.8B, led by a 15% increase in sales and service revenues. However, the company's cash and cash equivalents fell sharply to $35.1B from $47.7B at year-end 2025, and the company spent $4.5B on share repurchases during the quarter, while total cash and equivalents including restricted cash dropped to $41.4B from $101.2B a year earlier.

  • · Net cash flows from operating activities were $21.7B in H1 2026, up slightly from $21.0B in H1 2025.
  • · Net cash flows from investing activities were -$28.6B in H1 2026 vs +$33.0B in H1 2025, a swing of $61.6B due to large equity and Treasury purchases.
  • · Berkshire spent $9.7B on business acquisitions in H1 2026 vs just $101M in H1 2025.
  • · Share repurchases totaled $4.5B in Q2 2026 and $4.4B in H1 2026, compared to zero in H1 2025.
  • · Equity method earnings swung from a loss of $4.7B in Q2 2025 to a gain of $248M in Q2 2026.
  • · Accumulated other comprehensive income was -$2.97B at June 30, 2026 vs -$2.45B at Dec 31, 2025, a decline of $523M.
  • · Treasury stock at cost increased to $83.7B from $78.9B at year-end 2025, reflecting buybacks.
  • · Insurance underwriting expenses rose 7.5% to $4.8B in Q2 2026 from $4.5B in Q2 2025.
  • · Selling, general and administrative expenses decreased 15.2% to $6.7B in Q2 2026 from $7.9B in Q2 2025.
  • · Income tax expense more than doubled to $6.3B in Q2 2026 from $2.3B in Q2 2025, reflecting higher pre-tax earnings.
General Enterprise Ventures, Inc. 10-Q mixed materiality 8/10

10-08-2026

General Enterprise Ventures, Inc. (GEVI) reported a net loss of $3.9M for Q2 2026, a significant improvement from the $11.9M loss in Q2 2025, driven by lower financing expenses and the absence of large non-cash charges. However, revenue declined sharply by 59% to $280,666 from $687,638 in the prior-year quarter, and operating expenses remained elevated at $3.77M, resulting in a wider operating loss of $3.49M. Cash reserves fell by 60% to $2.52M from $6.27M at year-end 2025, while total assets decreased to $10.04M from $14.18M.

  • · Total liabilities decreased 65% to $1.02M at June 30, 2026 from $2.92M at December 31, 2025, primarily due to conversion of convertible notes and repayment of related-party payables.
  • · Operating loss widened 15.8% YoY to $3.49M in Q2 2026 and 22.6% to $7.94M in H1 2026, driven by higher payroll, professional fees, and R&D expenses.
  • · Net cash used in operating activities increased to $3.84M in H1 2026 from $1.93M in H1 2025, reflecting higher cash burn.
  • · The company issued 2.33M common shares upon conversion of Series C Preferred Stock and 941k shares for debt conversion during Q2 2026.
  • · Management stock compensation was $1.30M in Q2 2026 and $3.42M in H1 2026, a significant component of operating expenses.
  • · Accumulated deficit grew to $123.3M at June 30, 2026 from $113.2M at December 31, 2025.
  • · The company had no derivative liability at June 30, 2026, compared to a $3.78M loss on fair value of derivative liability in H1 2025.
  • · Deferred revenue increased to $21,394 at June 30, 2026 from $3,000 at December 31, 2025.
IonQ, Inc. 10-Q mixed materiality 9/10

10-08-2026

IonQ reported Q2 2026 revenue of $80.05M, up 287% YoY from $20.69M, driven by strong customer adoption. However, the net loss widened significantly to $1.87B from $177.5M in Q2 2025, primarily due to a $1.65B non-cash loss on the change in fair value of warrant liabilities. Operating expenses more than doubled, with R&D spending up 55% and G&A up 144%, reflecting the company's continued investment in growth and acquisitions.

  • · Net loss per share (basic and diluted) was $(5.08) for Q2 2026, compared to $(0.70) for Q2 2025.
  • · Operating cash flow used $254.78M in H1 2026, up from $85.60M used in H1 2025.
  • · Investing activities provided $442.12M in H1 2026, driven by maturities and sales of available-for-sale securities, compared to $200.98M used in H1 2025.
  • · Financing activities provided $18.92M in H1 2026, down from $372.86M in H1 2025, as the prior period included $358.25M in proceeds from common stock and warrant issuance.
  • · Total comprehensive loss attributable to IonQ was $1.87B for Q2 2026 vs $172.76M for Q2 2025.
  • · Goodwill increased to $2.19B as of June 30, 2026 from $1.96B at December 31, 2025, reflecting acquisitions.
  • · Intangible assets, net were $778.87M as of June 30, 2026, up from $767.43M at December 31, 2025.
  • · Noncontrolling interests were $12.37M as of June 30, 2026, down from $14.18M at December 31, 2025.
Galaxy Gaming, Inc. 10-Q mixed materiality 7/10

10-08-2026

Galaxy Gaming reported net income of $996,978 for Q2 2026, up 4.9% from $950,357 in Q2 2025, and net income of $2,364,534 for the first half of 2026 versus a net loss of $1,070,925 in the prior-year period. Total revenue grew 5.4% to $7,937,890 in Q2 and 1.9% to $15,600,451 in H1, driven by strong EMEA growth (+15.1% in Q2, +12.6% in H1). However, the Americas segment declined 2.1% in Q2 and 6.2% in H1, and operating income slipped 2.3% in Q2. The company reduced its total liabilities from $44,974,894 to $42,113,090 and narrowed its stockholders' deficit from $17,474,275 to $15,154,370.

  • · Selling, general and administrative expenses increased 15.2% to $4,852,606 in Q2 2026 from $4,213,470 in Q2 2025.
  • · Research and development expenses decreased 47.1% to $128,553 in Q2 2026 from $243,162 in Q2 2025.
  • · Interest expense decreased 10.3% to $813,483 in Q2 2026 from $906,598 in Q2 2025.
  • · The company had a loss on extinguishment of debt of $2,969,585 in H1 2025, with none in H1 2026.
  • · Cash and cash equivalents increased by $451,115 during H1 2026, compared to a decrease of $13,078,794 in H1 2025.
  • · Investment in internally developed software increased 49.9% to $726,408 in H1 2026 from $484,741 in H1 2025.
  • · Assets deployed at client locations increased 16.6% to $4,809,357 as of June 30, 2026 from $4,125,723 as of December 31, 2025.
  • · Accumulated deficit improved to $35,903,083 as of June 30, 2026 from $38,267,617 as of December 31, 2025.
  • · The company's total stockholders' deficit improved by $2,319,905 during H1 2026.
Invest Green Acquisition Corp 10-Q mixed materiality 5/10

10-08-2026

Invest Green Acquisition Corp (IGACU) reported net income of $1.3M for Q2 2026 and $2.6M for H1 2026, driven by interest income on trust assets, compared to a net loss of $42,482 in the prior-year inception period. However, operating losses widened to $245,904 in Q2 2026 from $42,482 in the comparable prior period, and the company continues to report a shareholders' deficit of $7.3M, reflecting ongoing costs without a completed business combination.

  • · Operating loss for Q2 2026 was $245,904, up from $42,482 in the prior-year inception period.
  • · Total shareholders' deficit increased to $7.3M at June 30, 2026 from $6.8M at December 31, 2025.
  • · The company had a working capital note of $896,740 and deferred underwriting fees of $6.9M as of June 30, 2026.
  • · Accretion for Class A ordinary shares to redemption amount totaled $1.5M in Q2 2026 and $3.1M for H1 2026.
  • · Cash used in operating activities was $216,069 for H1 2026, compared to zero in the prior-year inception period.
Lincoln International, Inc. 10-Q mixed materiality 9/10

10-08-2026

Lincoln International, Inc. reported a net loss of $22.95M for Q2 2026, compared to net income of $33.54M in Q2 2025, driven by a $15.88M operating loss versus a $32.14M operating profit in the prior-year quarter. Revenue grew 50.8% YoY to $225.69M, but expenses surged 105.6% to $241.57M, including a $35.35M spike in other operating expenses and a $28.68M non-cash charge for Liquidity Event share awards related to the company's IPO. The company completed an IPO during the quarter, raising $451.53M in net proceeds, and used $254.49M to distribute proceeds to partners and $196.64M to repay long-term debt.

  • · Other operating expenses, net surged to $35.35M in Q2 2026 from $6.64M in Q2 2025, a 432% increase.
  • · Depreciation and amortization rose to $19.25M in Q2 2026 from $11.15M in Q2 2025, up 72.6%.
  • · Compensation and benefits expense increased to $145.78M in Q2 2026 from $70.80M in Q2 2025, up 105.9%.
  • · Professional services and development expense rose to $18.38M in Q2 2026 from $9.19M in Q2 2025, up 100.1%.
  • · Cash provided by operating activities was $103.30M in H1 2026 versus $79.79M in H1 2025, a 29.5% increase.
  • · The company established a deferred tax liability of $19.59M and an amount due pursuant to tax receivable agreement of $84.76M in connection with the IPO.
  • · Goodwill increased slightly to $277.97M at June 30, 2026 from $274.47M at December 31, 2025.
  • · Other intangible assets, net decreased to $82.45M from $115.90M, a 28.9% decline.
  • · Redeemable noncontrolling interest was $7.27M at June 30, 2026, down from $7.42M at December 31, 2025.
  • · The company had no Class A, B, or C common stock authorized, issued, or outstanding at December 31, 2025, reflecting the pre-IPO partnership structure.
Vistra Corp. 10-Q mixed materiality 9/10

10-08-2026

Vistra Corp. reported strong financial results for Q2 and H1 2026, with net income attributable to common stock rising to $258 million in Q2 2026 from $280 million in Q2 2025, and H1 2026 net income surging to $1,238 million from a loss of $37 million in H1 2025. Revenue decreased 5.5% in Q2 to $4,017 million from $4,250 million, but H1 revenue increased 18% to $9,657 million from $8,183 million. Operating income improved to $553 million in Q2 from $515 million, and H1 operating income jumped to $2,052 million from $395 million, driven by lower impairment charges and improved margins. However, cash flow from operations increased to $2,222 million in H1 2026 from $1,171 million in H1 2025, while capital expenditures rose to $1,572 million from $1,458 million.

  • · Total assets increased to $42,603 million as of June 30, 2026 from $41,550 million at December 31, 2025.
  • · Total liabilities increased to $37,109 million from $36,440 million over the same period.
  • · Long-term debt (less current portion) rose to $17,719 million from $15,842 million.
  • · Stockholders' equity improved to $5,482 million from $5,097 million.
  • · The company repurchased $709 million in stock during H1 2026, up from $589 million in H1 2025.
  • · Dividends paid to common stockholders were $154 million in H1 2026, slightly up from $152 million in H1 2025.
  • · Net cash used in financing activities was $1,284 million in H1 2026, compared to $227 million in H1 2025.
  • · The company had no short-term borrowings as of June 30, 2026, down from $1,800 million at year-end 2025.
  • · Accounts receivable financing decreased to $300 million from $1,225 million.
  • · Commodity and other derivative contractual assets (current) increased to $3,663 million from $2,793 million.
  • · Commodity and other derivative contractual liabilities (current) increased to $4,893 million from $4,049 million.
Goldman Sachs Private Credit Corp. 10-Q mixed materiality 8/10

10-08-2026

Goldman Sachs Private Credit Corp. reported net investment income of $218.9M for Q2 2026 (up 45.7% YoY from $150.2M) and $439.5M for H1 2026 (up 50.7% YoY from $291.6M), driven by strong portfolio growth. However, net asset value per share declined to $24.57 from $24.99 at year-end 2025, and the company recorded a net realized and unrealized loss of $179.4M for H1 2026, compared to a loss of $36.0M in the prior year period, reflecting mark-to-market pressure on investments.

  • · Interest and other debt expenses surged 165% YoY to $120.7M in Q2 2026 and 170% YoY to $227.5M in H1 2026, reflecting higher borrowing costs and increased debt levels.
  • · Net expenses (after fee waivers and expense support) rose 128% YoY to $165.1M in Q2 2026 and 152% YoY to $308.4M in H1 2026.
  • · The company's distributable earnings (loss) worsened to a negative $226.2M as of June 30, 2026, from a negative $64.9M at December 31, 2025.
  • · Net cash used in operating activities was $2.21B in H1 2026, up 8.2% from $2.05B in H1 2025.
  • · Share repurchases (Class I) increased significantly: $296.5M in Q2 2026 vs $140.2M in Q2 2025, and $721.8M in H1 2026 vs $207.2M in H1 2025.
  • · The company launched Class S and Class D shares during H1 2026, with net assets of $5.1M and $0.4M respectively as of June 30, 2026.
  • · Interest rate swaps had a total notional amount of $3.75B with a negative fair value of $59.5M as of June 30, 2026.
  • · Total investments at fair value were $18.19B (cost $18.39B), representing 197.8% of net assets, indicating leverage.
PLAINS GP HOLDINGS LP 10-Q mixed materiality 8/10

10-08-2026

Plains GP Holdings LP (PAGP) reported a surge in net income attributable to PAGP to $389M in Q2 2026 (from $30M in Q2 2025) and $408M in H1 2026 (from $114M in H1 2025), driven largely by a $1,649M gain from discontinued operations (Canadian NGL business divestiture). However, income from continuing operations, net of tax, declined to $166M in Q2 2026 from $213M in Q2 2025, and PAGP reported a net loss from continuing operations of $74M in Q2 2026 versus a $10M profit in the prior-year quarter. Total revenues more than doubled to $17,693M in Q2 2026 from $10,642M in Q2 2025, but operating income rose to $397M from $237M.

  • · The Canadian NGL business divestiture contributed $1,649M to net income in Q2 2026 and $1,548M in H1 2026.
  • · Current assets of discontinued operations were $479M at Dec 31, 2025 and zero at June 30, 2026, reflecting the completion of the divestiture.
  • · Cash paid in connection with acquisitions dropped to $130M in H1 2026 from $681M in H1 2025.
  • · Net cash used in financing activities was $3,725M in H1 2026, driven by $1,100M repayment under PAA term loan and $750M repayments of PAA senior notes.
  • · Proceeds from issuance of PAA senior notes were $998M in H1 2025, with no similar issuance in H1 2026.
  • · Repurchase of Series A preferred units by a subsidiary was $333M in H1 2025, with none in H1 2026.
  • · Equity earnings in unconsolidated entities were $89M in Q2 2026 vs $94M in Q2 2025, a slight decline.
  • · Interest expense increased to $135M in Q2 2026 from $110M in Q2 2025.
  • · Current income tax expense from continuing operations surged to $107M in Q2 2026 from $1M in Q2 2025.
  • · Basic net income per Class A share was $1.97 in Q2 2026 vs $0.15 in Q2 2025.
Expion360 Inc. 10-Q mixed materiality 8/10

10-08-2026

Expion360 Inc. reported a net loss of $1.28M for Q2 2026, an improvement from a $1.37M loss in Q2 2025, while net sales declined 32% YoY to $2.03M. For the first half of 2026, the net loss widened to $3.04M from $2.52M in the prior year period, with sales falling 29% to $3.60M. The company's cash position dropped sharply to $1.54M from $2.97M at year-end 2025, and total assets declined to $6.14M from $8.07M, while accumulated deficit grew to $43.85M.

  • · Net cash used in operating activities for H1 2026 was $2.61M, compared to $1.63M in H1 2025.
  • · Inventory decreased to $2.05M as of June 30, 2026 from $2.86M at December 31, 2025.
  • · Accounts receivable declined to $638,281 from $718,964 at year-end 2025.
  • · Total liabilities decreased to $1.32M from $1.54M at December 31, 2025.
  • · The company had no preferred shares issued or outstanding.
  • · Net loss per share improved to $(1.34) in Q2 2026 from $(4.93) in Q2 2025, and to $(3.33) from $(9.39) for the six-month periods, due to a significantly higher share count.
  • · Selling, general and administrative expenses were $1.96M in Q2 2026, roughly flat compared to $1.97M in Q2 2025, but increased to $4.13M for H1 2026 from $3.62M in H1 2025.
  • · The company has substantial customer concentration risk, with a limited number of customers accounting for a substantial portion of sales.
  • · Sales of substantial amounts of securities in the public markets, including under an at-the-market program, could reduce the stock price and dilute ownership.
PLAINS ALL AMERICAN PIPELINE LP 10-Q mixed materiality 9/10

10-08-2026

Plains All American Pipeline LP (PAA) reported a massive surge in net income attributable to PAA for Q2 2026, reaching $1,830 million compared to $210 million in Q2 2025, driven primarily by a $1,649 million gain from discontinued operations (the Canadian NGL business divestiture). However, income from continuing operations, net of tax, grew only modestly to $276 million from $227 million, and operating income improved to $398 million from $239 million. The company also significantly reduced total debt, with senior notes and other long-term debt declining from $10,696 million at year-end 2025 to $8,432 million at June 30, 2026.

  • · Total assets decreased from $30,169M at Dec 31, 2025 to $29,218M at June 30, 2026.
  • · Current assets of discontinued operations fell to $0 from $479M, reflecting the completion of the Canadian NGL divestiture.
  • · Net cash provided by operating activities from continuing operations was $1,214M for H1 2026 vs $1,032M for H1 2025.
  • · Net cash provided by investing activities from discontinued operations was $3,451M in H1 2026, compared to ($106M) used in H1 2025.
  • · The company repaid $1,100M under a term loan and $750M of senior notes during H1 2026.
  • · Distributions paid to common unitholders increased to $589M in H1 2026 from $535M in H1 2025.
  • · Equity earnings in unconsolidated entities decreased slightly to $89M in Q2 2026 from $94M in Q2 2025.
  • · Interest expense increased to $153M in Q2 2026 from $133M in Q2 2025.
EASTERN GAS TRANSMISSION & STORAGE, INC. 10-Q mixed materiality 8/10

10-08-2026

Eastern Gas Transmission & Storage, Inc. reported strong Q2 2026 results with net income attributable to BHE shareholders up 26.9% YoY to $891M, driven by higher energy revenue and improved operating income. However, the company recorded a $172M equity loss in Q2 (vs. $160M loss a year ago) and total comprehensive income fell 30.7% YoY due to a $64M foreign currency translation loss. Total assets grew 3.8% to $154,029M, while total liabilities increased 4.2% to $96,908M, partly due to higher subsidiary debt.

  • · Assets held for sale of $2,008M and liabilities held for sale of $246M as of June 30, 2026, indicating a planned disposition (Note 3).
  • · Subsidiary junior subordinated debt increased from $1,584M to $3,266M during H1 2026.
  • · Current portion of long-term debt decreased from $1,455M to $628M during H1 2026.
  • · Short-term debt decreased from $1,997M to $1,374M during H1 2026.
  • · Accumulated other comprehensive loss widened from $(1,844)M to $(2,035)M during H1 2026.
  • · Wildfires liabilities (current) decreased sharply from $734M to $155M during H1 2026.
  • · Real estate revenue was nearly flat: Q2 2026 $1,273M vs Q2 2025 $1,264M (+0.7% YoY); H1 2026 $2,135M vs H1 2025 $2,124M (+0.5% YoY).
  • · Energy revenue grew 5.5% YoY in Q2 and 5.5% YoY in H1.
  • · Interest expense increased 11.6% YoY in Q2 ($791M vs $709M) and 10.2% YoY in H1 ($1,537M vs $1,395M).
  • · Gains on marketable securities fell from $119M in H1 2025 to $15M in H1 2026 (-87.4%).
Brookfield Asset Management Ltd. 10-Q positive materiality 8/10

10-08-2026

Brookfield Asset Management Ltd. reported strong Q2 2026 results with net income attributable to common stockholders of $904M, up 45.8% YoY from $620M, driven by a significant swing in unrealized carried interest allocations to a gain of $553M from a loss of $63M. Total revenues grew 60.8% YoY to $1,753M, while total expenses increased 18.3% to $659M. However, the company's cash position declined to $1,503M from $1,583M at year-end 2025, and the retained deficit widened to $950M from $851M.

  • · Total assets grew to $20.1B as of June 30, 2026, up from $17.0B at Dec 31, 2025.
  • · Total liabilities increased to $8.2B from $6.7B over the same period.
  • · Corporate borrowings rose to $3.5B from $2.5B.
  • · The company repurchased $576M in treasury shares during H1 2026, compared to $116M in H1 2025.
  • · Distributions to common stockholders totaled $1.6B in H1 2026, up from $1.4B in H1 2025.
  • · Basic EPS for Q2 2026 was $0.56, up from $0.38 in Q2 2025.
  • · Diluted EPS for Q2 2026 was $0.56, up from $0.38 in Q2 2025.
CORPAY, INC. 10-Q mixed materiality 9/10

10-08-2026

Corpay, Inc. reported mixed results for Q2 2026. Revenues increased 21.5% YoY to $1.34B for the quarter and 23.3% to $2.60B for the first half, driven by strong organic growth and acquisitions. However, net income attributable to Corpay declined 12.6% YoY to $248.3M in Q2, impacted by a $100M legal settlement provision and higher interest expense. Diluted EPS fell 7.0% to $3.70, while basic EPS dropped 6.9% to $3.75. The company also significantly ramped up share repurchases, buying back $1.11B in stock during the first half of 2026.

  • · Total assets increased to $28.22B at June 30, 2026 from $26.41B at December 31, 2025.
  • · Goodwill decreased to $7.15B from $7.56B, likely due to a business disposition.
  • · The company recorded a $122.5M gain on disposition of a business in H1 2026, with $421.7M in proceeds.
  • · Total debt (current portion of notes payable and lines of credit plus notes payable and other obligations, less current portion) was $8.32B at June 30, 2026, up from $8.18B at December 31, 2025.
  • · The company had a $100M provision for legal settlement in H1 2026.
  • · Share repurchases totaled $1.11B in H1 2026, compared to $90.9M in H1 2025.
  • · Diluted share count decreased to 66.3M in Q2 2026 from 71.4M in Q2 2025, reflecting the buyback impact.
  • · Cash and cash equivalents and restricted cash rose to $10.17B at June 30, 2026 from $5.53B a year earlier.
  • · Foreign currency translation losses of $16.7M in H1 2026 vs. gains of $424.9M in H1 2025.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Earnings Financial Results SEC Filings

August 06, 2026

US Earnings Financial Results SEC Filings — August 06, 2026

August 04, 2026

US Earnings Financial Results SEC Filings — August 04, 2026

August 03, 2026

US Earnings Financial Results SEC Filings — August 03, 2026

July 31, 2026

US Earnings Financial Results SEC Filings — July 31, 2026

🇺🇸 More from United States

View all →

August 11, 2026

US Pre-Market SEC Filings Roundup — August 11, 2026

US Pre-Market SEC Filings Roundup

August 11, 2026

USA Corporate Events Calendar — August 11, 2026

USA Corporate Events Calendar

August 11, 2026

USA Earnings Calls Schedule — August 11, 2026

USA Earnings Calls Schedule

August 11, 2026

US Executive Compensation Proxy SEC Filings — August 11, 2026

US Executive Compensation Proxy SEC Filings
← All United States digests